About Jumpcode Genomics

JUMPCODE offers CRISPR-mediated rRNA depletion kits, including DepleteX™ and CRISPRclean®, that enhance next-generation sequencing (NGS) workflows by removing uninformative nucleic acids. This technology improves sensitivity and data quality across various genomic applications, including single-cell analysis and microbiome characterization.

```xml <problem> In next-generation sequencing (NGS), a significant portion of sequenced molecules are often uninformative, leading to reduced sensitivity and inefficient data acquisition. The presence of undesired nucleic acid fragments, such as ribosomal RNA (rRNA), can obscure the detection of relevant genomic information in various applications. </problem> <solution> JUMPCODE provides CRISPR-mediated rRNA depletion kits, including DepleteX™ and CRISPRclean®, designed to enhance NGS workflows by removing these uninformative nucleic acids. This targeted depletion improves the proportion of usable data, boosting sensitivity and data quality across a range of genomic applications. The kits offer both pre-designed and custom depletion panels to remove specific undesired fragments, enabling researchers to focus on the most relevant genomic information. By reducing common noise, JUMPCODE's technology enhances discovery in areas such as single-cell analysis, microbiome characterization, infectious disease detection, and whole transcriptome profiling. </solution> <features> - CRISPR-mediated depletion of ribosomal RNA (rRNA) and other undesired nucleic acid fragments - DepleteX™ kit for broad depletion of ribosomal, mitochondrial, and non-variable genes in single-cell analysis - CRISPRclean® kit for unbiased human DNA and RNA depletion in metagenomics applications - Targeted depletion of ribosomal and globin RNA, or the top 70% of human mRNA, for whole transcriptome profiling - Custom depletion panels available for targeting specific sequences in any genomic application, from one to over a million targets - Plant and animal-specific depletion options for improved GBS and metagenomics in agrigenomics </features> <target_audience> The primary audience includes researchers and scientists in genomics, molecular biology, and related fields who utilize next-generation sequencing for applications such as single-cell analysis, microbiome characterization, infectious disease research, and whole transcriptome profiling. </target_audience> ```

What does Jumpcode Genomics do?

Where is Jumpcode Genomics located?

Jumpcode Genomics is based in Carlsbad, United States.

When was Jumpcode Genomics founded?

Jumpcode Genomics was founded in 2015.

How much funding has Jumpcode Genomics raised?

Jumpcode Genomics has raised 44170000.

Location

Carlsbad, United States

Founded

2015

Funding

44170000

Employees

15 employees

Major Investors

Arboretum Ventures, Baird Capital

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Jumpcode Genomics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

jumpcodegenomics.com 2K+

Crunchbase

Founded 2015 – Carlsbad, United States

Funding

Estimated Funding

$20M+

Major Investors

Arboretum Ventures, Baird Capital

Team (15+)

No team information available.

Company Description

Problem

In next-generation sequencing (NGS), a significant portion of sequenced molecules are often uninformative, leading to reduced sensitivity and inefficient data acquisition. The presence of undesired nucleic acid fragments, such as ribosomal RNA (rRNA), can obscure the detection of relevant genomic information in various applications.

Solution

JUMPCODE provides CRISPR-mediated rRNA depletion kits, including DepleteX™ and CRISPRclean®, designed to enhance NGS workflows by removing these uninformative nucleic acids. This targeted depletion improves the proportion of usable data, boosting sensitivity and data quality across a range of genomic applications. The kits offer both pre-designed and custom depletion panels to remove specific undesired fragments, enabling researchers to focus on the most relevant genomic information. By reducing common noise, JUMPCODE's technology enhances discovery in areas such as single-cell analysis, microbiome characterization, infectious disease detection, and whole transcriptome profiling.

Features

CRISPR-mediated depletion of ribosomal RNA (rRNA) and other undesired nucleic acid fragments

DepleteX™ kit for broad depletion of ribosomal, mitochondrial, and non-variable genes in single-cell analysis

CRISPRclean® kit for unbiased human DNA and RNA depletion in metagenomics applications

Targeted depletion of ribosomal and globin RNA, or the top 70% of human mRNA, for whole transcriptome profiling

Custom depletion panels available for targeting specific sequences in any genomic application, from one to over a million targets

Plant and animal-specific depletion options for improved GBS and metagenomics in agrigenomics

Target Audience

The primary audience includes researchers and scientists in genomics, molecular biology, and related fields who utilize next-generation sequencing for applications such as single-cell analysis, microbiome characterization, infectious disease research, and whole transcriptome profiling.